Pfizer Lowers Targeted Revenues for 2012; Wall Street Remains Skeptical
Pfizer's touts growth plans in emerging markets as the pharma prepares for the onset of Lipitor generics.
Pfizer's touts growth plans in emerging markets as the pharma prepares for the onset of Lipitor generics.